L-Asparaginase-SAGO® Injection 10,000 IU
A lyophilized enzymatic anticancer therapy used primarily in acute lymphoblastic leukemia treatment protocols.
Description
L-Asparaginase-SAGO® is a lyophilized injectable enzyme preparation containing L-asparagine amidohydrolase derived from Escherichia coli. The product works by depleting circulating L-asparagine, an essential amino acid required for the growth of certain leukemic cells. This targeted mechanism makes it a cornerstone therapy in pediatric and adult acute lymphoblastic leukemia protocols. The product is supplied as a single-use vial and requires reconstitution prior to IM or IV administration.
Parturient ut id tellus vulputatre ac ultrlices a part ouriesnt sapien dignissim partu rient a a inter drum vehicula. Ornare metus laoreet tincidunt eros rolem tristique pretium malada.
Cras rhoncus vivamus luctus platea arcu laoreet selm. Curae est condenectus sed hac a parturient vestibulum.
-
Acute lymphoblastic leukemia (ALL)
-
Leukemia resistant to conventional cytotoxic agents
-
Combination chemotherapy regimens in oncology protocols
Reviews
There are no reviews yet.